Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IN-M00002 PK and Food Effect Study
NCT07277712Phase 1Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Dec 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan + naproxen in pain and gastric ulcer, sponsored by HK inno.N Corporation. Primary endpoints: Area Under the Plasma Concentration-Time Curve of tegoprazan at 48 hours, Area Under the Plasma Concentration-Time Curve of naproxen at 72 hours and 2 more. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegoprazan + naproxen
03
Conditions
paingastric ulcer
Beyond the preview
Go deeper on NCT07277712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07277712.